Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 May 1998 | Volume 128 Issue 9 | Pages 745-755
For this article, the literature on the pathophysiology, clinical features, natural history, prognosis, and management of the Eisenmenger syndrome in adults was reviewed.English-language articles from 1966 to the present were identified through a search of the MEDLINE database by using the terms Eisenmenger, congenital heart disease, and pulmonary hypertension. Selected cross-referenced articles were also included. Articles on the pathophysiology, clinical presentation, evaluation, natural history, complications, and treatment of the Eisenmenger syndrome in adults were selected, and descriptive and analytical data relevant to the practicing physician were manually extracted.
The Eisenmenger syndrome is characterized by elevated pulmonary vascular resistance and right-to-left shunting of blood through a systemic-to-pulmonary circulation connection. Most patients with the syndrome survive for 20 to 30 years. The hemostatic changes associated with the syndrome may lead to thromboembolic events, cerebrovascular complications, or the hyperviscosity syndrome. Erythrocytosis is present in most patients, but excessive phlebotomy may cause microcytosis and exacerbate the symptoms of hyperviscosity. Other complications associated with the Eisenmenger syndrome include hemoptysis, gout, cholelithiasis, hypertrophic osteoarthropathy, and decreased renal function. Pregnancy or noncardiac surgery is associated with a high mortality rate in patients with the Eisenmenger syndrome. Because most pediatric patients with the Eisenmenger syndrome survive to adulthood, primary care physicians should have a thorough understanding of the syndrome; its associated complications; and medical and surgical management, especially with regard to the appropriate timing of phlebotomy and lung or heart-lung transplantation. In addition, patients with the syndrome should undergo routine follow-up at a tertiary care center that has physicians and nurses with special expertise in congenital heart disease. In patients with the Eisenmenger syndrome who are pregnant or require noncardiac surgery, a multidisciplinary approach should be used to reduce the excessive mortality associated with these conditions.
Author and Article Information
From University of Texas Southwestern Medical Center, Dallas, Texas.
REVIEW
The Eisenmenger Syndrome in Adults
![]()
Requests for Reprints: Richard A. Lange, MD, Room CS 7.102, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75235-9047.
Current Author Addresses: Drs. Vongpatanasin, Brickner, Hillis, and Lange: Room CS 7.102, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75235-9047.
This article has been cited by other articles:
![]() |
S C Apostolopoulou, A Manginas, D V Cokkinos, and S Rammos Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study Heart, March 1, 2007; 93(3): 350 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-P. Diller and M. A. Gatzoulis Pulmonary Vascular Disease in Adults With Congenital Heart Disease Circulation, February 27, 2007; 115(8): 1039 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Levy, C. Maurey, D. S. Celermajer, P. R. Vouhe, C. Danel, D. Bonnet, and D. Israel-Biet Impaired Apoptosis of Pulmonary Endothelial Cells Is Associated With Intimal Proliferation and Irreversibility of Pulmonary Hypertension in Congenital Heart Disease J. Am. Coll. Cardiol., February 20, 2007; 49(7): 803 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mukhopadhyay, M. Sharma, S. Ramakrishnan, J. Yusuf, M. D. Gupta, N. Bhamri, V. Trehan, and S. Tyagi Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome: A Preliminary Observational Study Circulation, October 24, 2006; 114(17): 1807 - 1810. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Galie, M. Beghetti, M. A. Gatzoulis, J. Granton, R. M.F. Berger, A. Lauer, E. Chiossi, M. Landzberg, and for the Bosentan Randomized Trial of Endothelin An Bosentan Therapy in Patients With Eisenmenger Syndrome: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Circulation, July 4, 2006; 114(1): 48 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Adriaenssens, M. Delcroix, K. Van Deyk, and W. Budts Advanced therapy may delay the need for transplantation in patients with the Eisenmenger syndrome Eur. Heart J., June 2, 2006; 27(12): 1472 - 1477. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Caramuru, A. A. Lopes, N. Y. Maeda, V. D. Aiello, and C. C. Filho Long-term Behavior of Endothelial and Coagulation Markers in Eisenmenger Syndrome Clinical and Applied Thrombosis/Hemostasis, April 1, 2006; 12(2): 175 - 183. [Abstract] [PDF] |
||||
![]() |
I. A. Russell, K. Rouine-Rapp, G. Stratmann, and W. C. Miller-Hance Congenital heart disease in the adult: a review with internet-accessible transesophageal echocardiographic images. Anesth. Analg., March 1, 2006; 102(3): 694 - 723. [Full Text] [PDF] |
||||
![]() |
Task Force members, N. Galie, A. Torbicki, R. Barst, P. Dartevelle, S. Haworth, T. Higenbottam, H. Olschewski, A. Peacock, G. Pietra, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology Eur. Heart J., December 2, 2004; 25(24): 2243 - 2278. [Full Text] [PDF] |
||||
![]() |
M.C. Post, S. Janssens, F. Van de Werf, and W. Budts Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension Eur. Heart J., September 2, 2004; 25(18): 1651 - 1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Corno, Y. Boone, I. Mallabiabarrena, M. Augstburger, P. Tozzi, E. Ferrari, and L. K. von Segesser Myocardial and pulmonary effects of aqueous oxygen with acute hypoxia Ann. Thorac. Surg., September 1, 2004; 78(3): 956 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Corno, Y. Boone, I. Mallabiabarrena, M. Augstburger, and L. K. von Segesser Aqueous oxygen: the solution to relief hypoxic pulmonary hypertension Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 301 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-R. Chou, P.-H. Kuo, J.-C. Shih, and P.-C. Yang A 31-Year-Old Pregnant Woman With Progressive Exertional Dyspnea and Differential Cyanosis Chest, August 1, 2004; 126(2): 638 - 641. [Full Text] [PDF] |
||||
![]() |
L. H. Caramuru, N. Y. Maeda, S. P. Bydlowski, and A. A. Lopes Age-Dependent Likelihood of In Situ Thrombosis in Secondary Pulmonary Hypertension Clinical and Applied Thrombosis/Hemostasis, July 1, 2004; 10(3): 217 - 223. [Abstract] [PDF] |
||||
![]() |
C. K. Silversides, J. T. Granton, E. Konen, M. A. Hart, G. D. Webb, and J. Therrien Pulmonary thrombosis in adults with Eisenmenger syndrome J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1982 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Caramuru, R. D. P. S. Soares, N. Y. Maeda, and A. A. Lopes Hypoxia and Altered Platelet Behavior Influence von Willebrand Factor Multimeric Composition in Secondary Pulmonary Hypertension Clinical and Applied Thrombosis/Hemostasis, July 1, 2003; 9(3): 251 - 258. [Abstract] [PDF] |
||||
![]() |
A. F. Corno, P. Tozzi, C. Y. Genton, and L. K. von Segesser Surgically induced unilateral pulmonary hypertension: time-related analysis of a new experimental model Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 513 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Petrofski, C. W. Hoopes, T. M. Bashore, S. D. Russell, and C. A. Milano Mechanical ventricular support lowers pulmonary vascular resistance in a patient with congential heart disease Ann. Thorac. Surg., March 1, 2003; 75(3): 1005 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Lopes, L. H. Caramuru, and N. Y. Maeda Endothelial Dysfunction Associated with Chronic Intravascular Coagulation in Secondary Pulmonary Hypertension Clinical and Applied Thrombosis/Hemostasis, October 1, 2002; 8(4): 353 - 358. [Abstract] [PDF] |
||||
![]() |
M. Humbert, P. Labrune, O. Sitbon, C. Le Gall, J. Callebert, P. Herve, D. Samuel, R. Machado, R. Trembath, L. Drouet, et al. Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis Eur. Respir. J., July 1, 2002; 20(1): 59 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Horigome, Y. Hiramatsu, O. Shigeta, T. Nagasawa, and A. Matsui Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia J. Am. Coll. Cardiol., March 20, 2002; 39(6): 1072 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Previte and P. Haran Eisenmenger Syndrome Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2001; 5(1): 67 - 78. [Abstract] [PDF] |
||||
![]() |
I. L. Marples, M. J. Heap, S. K. Suvarna, and G. H. Mills Acute right-to-left inter-atrial shunt; an important cause of profound hypoxia Br. J. Anaesth., December 1, 2000; 85(6): 921 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Oya, N Nagaya, T Satoh, F Sakamaki, S Kyotani, M Fujita, N Nakanishi, and K Miyatake Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome Heart, July 1, 2000; 84(1): 53 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Brickner, L. D. Hillis, and R. A. Lange Congenital Heart Disease in Adults- Second of Two Parts N. Engl. J. Med., February 3, 2000; 342(5): 334 - 342. [Full Text] [PDF] |
||||
![]() |
J.-R. Tang, T. D. le Cras, K. G. Morris Jr., and S. H. Abman Brief perinatal hypoxia increases severity of pulmonary hypertension after reexposure to hypoxia in infant rats Am J Physiol Lung Cell Mol Physiol, February 1, 2000; 278(2): L356 - L364. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Veyssier-Belot and P. Cacoub Role of endothelial and smooth muscle cells in the physiopathology and treatment management of pulmonary hypertension Cardiovasc Res, November 1, 1999; 44(2): 274 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Niwa, J. K. Perloff, S. Kaplan, J. S. Child, and P. D. Miner Eisenmenger syndrome in adults: Ventricular septal defect, truncus arteriosus, univentricular heart J. Am. Coll. Cardiol., July 1, 1999; 34(1): 223 - 232. [Abstract] [Full Text] [PDF] |
||||